• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Synta Pharmaceuticals Corp. (SNTA)

    -NasdaqGM
    2.80 Down 0.06(2.10%) 4:00PM EST
    |After Hours : 2.80 0.00 (0.00%) 5:00PM EST
    Add to Portfolio
    Prev Close:2.86
    Open:2.84
    Bid:N/A
    Ask:4.85 x 1000
    1y Target Est:10.88
    Beta:1.57
    Earnings Date:Mar 9 - Mar 13 (Est.)
    Day's Range:2.72 - 2.85
    52wk Range:2.54 - 7.22
    Volume:1,333,843
    Avg Vol (3m):1,184,850
    Market Cap:303.42M
    P/E (ttm):N/A
    EPS (ttm):-0.99
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SNTA

    Comparison

    Symbol% ChgMkt Cap
    SNTADown 2.10%303.42M
    INFIUp 3.14%864.62M
    NVSUp 0.04%228.83B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.89
    Quarterly EPS Est (Dec-14) :-0.21
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs for treating severe medical conditions, including cancer and chronic inflammatory diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback